Similar articles

• [Pirenzepin in the prevention and treatment of stress ulcer in critically ill patients].

  Santamaria LB, Picone F, Romeo C, Ripoli G, Famà S, Mandolfino T. Santamaria LB, et al. Minerva Anestesiol. 1986 Mar-Apr;52(3-4):101-5. Minerva Anestesiol. 1986. PMID: 3755810 Italian. No abstract available.
• [Prevention of gastroduodenal stress lesions with secretion inhibitors in accident patients needing intensive care: incidence of lesions and adverse effects; consequences].

  Barandun J, Leutenegger A, Frutiger A, Rüedi T, Kobler E. Barandun J, et al. Schweiz Med Wochenschr. 1985 Jul 20;115(29):1022-3. Schweiz Med Wochenschr. 1985. PMID: 3840276 Clinical Trial. German.
• [Use of pirenzepine in prevention of stress ulcers in high-risk surgical patients].

  Butti A, De Giovanni L, Reggio D, Valentini P, Civello IM. Butti A, et al. Minerva Med. 1986 May 12;77(20):867-72. Minerva Med. 1986. PMID: 3523298 Clinical Trial. Italian.
• Newer drugs in the treatment of peptic ulcer.

  Tandon BN. Tandon BN. Trop Gastroenterol. 1985 Oct-Dec;6(4):188-92. Trop Gastroenterol. 1985. PMID: 3913076 Review. No abstract available.
• Pirenzepine in the treatment of peptic ulcer disease. Review and commentary.

  Bianchi Porro G, Petrillo M. Bianchi Porro G, et al. Scand J Gastroenterol Suppl. 1982;72:229-36. Scand J Gastroenterol Suppl. 1982. PMID: 6753117 Review.